Track topics on Twitter Track topics that are important to you
Dyadic International Inc (NASDAQ:DYAI) board member Dr Arin Bose, a 34-year Pfizer (NYSE:PFE) veteran, talks to Proactive Investors about what went into choosing Dyadic's research partners VTT Technical Research Centre of Finland Ltd and Spain-based biotech BDI Holdings.
Original Article: Dyadic International board member highlights upcoming milestonesNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...